Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities
Jian Song, Yong-Feng Guan, Wen‐Bo Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114467-114467
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 73
Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies
Manankar Koley, Jianlin Han, Vadim A. Soloshonok, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 10-54
Open Access | Times Cited: 43
Syntheses, reactivity, and biological applications of coumarins
Andrea Citarella, Serena Vittorio, Christian Dank, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 18
Recent advances on biologically active coumarin-based hybrid compounds
Metin Yıldırım, Samet Poyraz, Mehmet Erşatır
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 617-642
Closed Access | Times Cited: 37
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 8
Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity
Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, Simone Giovannuzzi, et al.
International Journal of Biological Macromolecules (2025), pp. 140462-140462
Closed Access | Times Cited: 1
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 22
Mechanisms of anti-ulcer actions of Prangos pabularia (L.) in ethanol-induced gastric ulcer in rats
Ahmed Aj. Jabbar, Ramzi A. Mothana, Mahmood Ameen Abdulla, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101850-101850
Open Access | Times Cited: 18
Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers
Xin-Ying Yuan, Chun-Hong Song, Xiujuan Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115281-115281
Closed Access | Times Cited: 17
Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
Jian Song, Shenghui Wang, Chun-Hong Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114583-114583
Closed Access | Times Cited: 26
Tubulin degradation: Principles, agents, and applications
Yifan Zhang, Jiao Huang, Weixin Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106684-106684
Closed Access | Times Cited: 15
Targeting hematological malignancies with isoxazole derivatives
Monika Majirská, Martina Bago Pilátová, Z Kudlicková, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104059-104059
Open Access | Times Cited: 5
Design, synthesis and biological evaluation of novel 1H-indole-3-carbonitrile derivatives as potent TRK Inhibitors
Shaochun Xu, Xiao-Sheng Jiang, Mengdi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117231-117231
Closed Access
SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis
Shanshan Deng, Souvik Banerjee, Hao Chen, et al.
Cancer Letters (2022) Vol. 555, pp. 216046-216046
Open Access | Times Cited: 17
Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents
M Podolak, Serhii Holota, Yaroslava Deyak, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107076-107076
Open Access | Times Cited: 10
Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity
Kun Liu, Min Mo, Gang Yu, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106727-106727
Closed Access | Times Cited: 9
Novel tubulin polymerization inhibitors based on the hybridization of coumarin and indole ring: Design, synthesis and bioactivities evaluation
Wei Yang, Huining Peng, Min He, et al.
Journal of Molecular Structure (2024) Vol. 1305, pp. 137761-137761
Closed Access | Times Cited: 3
In Vitro and In Silico Study to Assess Toxic Mechanisms of Hybrid Molecules of Quinone-Benzocaine as Plastoquinone Analogues in Breast Cancer Cells
Ayşe Mine Yılmaz, Ayşe Tarbın Jannuzzi, Nilüfer Bayrak, et al.
ACS Omega (2022) Vol. 7, Iss. 34, pp. 30250-30264
Open Access | Times Cited: 15
Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay
Lexian Chen, Qianqian Lv, Jianghong Cai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents
Jiedan Deng, Lin Long, Peng Xue, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115366-115366
Closed Access | Times Cited: 8
Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities
Jian Song, Shuyu Wang, Xiao Wang, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106580-106580
Closed Access | Times Cited: 8
N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations
Jian Song, Shenghui Wang, Qiu-Ge Liu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 109678-109678
Closed Access | Times Cited: 2
Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities
Xin-Yi Tian, Weixin Zhang, Jia Yu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116079-116079
Closed Access | Times Cited: 6
Recent advances in the green synthesis of indole and its derivatives using microwave irradiation and the role of indole moiety in cancer
Faisal A. Almalki, Alaa O. Baryyan
Green Chemistry Letters and Reviews (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-a]pyrimidine Indole Derivatives against Gastric Cancer Cells MGC-803 via the Suppression of ERK Signaling Pathway
Guang-Xi Yu, Ying Hu, Weixin Zhang, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4996-4996
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top